CORNING, N.Y., – Corning Incorporated (NYSE: GLW) today announced that the company’s board of directors is expected to elect David L. Morse, Ph.D., as executive vice president and chief technology officer at its meeting on April 26, 2012. His appointment will be effective May 1, at which time he will also become a member of […]
Shanghai, China, – QIAGEN today announced that it has signed an agreement with Bio-X Center of Shanghai Jiao Tong University to open a joint translational medicine lab in Shanghai. The lab is the first of its kind between QIAGEN and a major research institution in China and is a key milestone in the Company’s expansion […]
NEW BRUNSWICK, NJ – Connotate, Inc., a leading provider of solutions that help organizations monitor and collect data and content from the Web, today announced that Sigma-Aldrich Corporation (NASDAQ: SIAL) has selected the Connotate solution to power its competitive pricing program. Sigma-Aldrich is a leading life science and high-technology company with more than 187,000 products […]
WARREN, N.J., — Roka Bioscience announced today that their Atlas Salmonella Detection Assay has received AOAC Performance Tested Methods(SM) certification from the AOAC Research Institute (AOAC-RI). The independent laboratory study was conducted by Silliker, Inc., as part of the AOAC-RI independent third-party validation process. The Atlas Salmonella Detection Assay runs on the Atlas System, an […]
Microlytic ApS announced that the company has secured USD 3.5 million in additional venture financing to expand sales and production operations in the Structural Biology sector. “Microlytic has the potential to revolutionize the process of protein crystallization by offering tools that significantly enhance success rates in crystallization, which is much needed in the industry, without […]
NEWARK, Calif.,– StemCells, Inc. (Nasdaq:STEM) and genOway (NYSE:ALGEN) announced today that they have entered into a license agreement under which StemCells has granted genOway a worldwide, exclusive license to StemCells’ Internal Ribosome Entry Site (IRES) technology for use in the development and commercialization of genetically engineered mice. Financial conditions were not disclosed. The IRES technology […]
New York, NY,– Enzo Biochem Inc. (NYSE: ENZ) announced today an expanded business arrangement between its wholly owned subsidiary, Enzo Life Sciences, and Tokyo-based Cosmo Bio Co., Ltd. (JASDAQ: 3386). Under the terms of the arrangement, Cosmo Bio—a distributor of Enzo Life Sciences products in Japan for over 20 years—will assume a leadership position in […]
Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase peptide synthesis (SPPS) of peptide-7-amino-4-carbamoylmethylcoumarin conjugates (peptide-ACCs) as an alternative for peptide-AMCs has been previously reported;1,2 no AMC solid […]
CARLSBAD, Calif.,– Life Technologies Corporation today announced the launch of GeneArt® Precision TALs, generally referred to as TAL effector proteins (TALE), which will allow researchers the ability to edit genomes and control gene activity with unprecedented precision and reliability. “We expect the GeneArt® TAL launch to be enthusiastically welcomed by the scientific community,” said Nathan […]
Celsis Rapid Detection announces today the launch of a new RapiScreen Soy Beverage kit, specifically designed for the detection of microbial contamination in soy and nut milks and similar beverage products. The RapiScreen Soy Beverage kit provides beverage manufacturers with test results in as few as 48 hours, compared to 4-14 days with traditional methods, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
